M K Proteins Ltd

As of 25-Nov, M K Proteins Ltd’s stock price has fallen to ₹6.27, reflecting a decline of 1.72% on the day and continuing a downward trend over recent weeks. This drop is underpinned by a combination of disappointing financial results, subdued investor participation, and persistent underperformance relative to market benchmarks.

M K Proteins' historical performance shows fluctuating revenue, with net sales increasing to 267.71 Cr in March 2025 from 245.57 Cr in March 2024, but declining from 314.86 Cr in March 2023. Profitability decreased, with operating profit falling to 12.43 Cr and cash flow showing a negative trend, indicating challenges in profitability and cash management despite some sales growth.

As of November 19, 2025, M K Proteins is considered very attractive and undervalued, with a PE ratio of 28.91, an EV to EBITDA of 18.57, and a ROCE of 17.66%, making it a compelling investment opportunity despite a year-to-date return of -20.34%.

M K Proteins has shown fluctuating financial performance, with net sales increasing to 267.71 Cr in March 2025 from 245.57 Cr in March 2024, but declining from 314.86 Cr in March 2023. Profitability has decreased, with profit after tax falling to 8.40 Cr in March 2025, and cash flow from operating activities turning negative at -16.00 Cr.

M K Proteins has shown fluctuating financial performance, with net sales increasing to 267.71 Cr in Mar'25 from 245.57 Cr in Mar'24, but down from 314.86 Cr in Mar'23. Key metrics like operating profit and profit after tax have decreased, while total assets and liabilities rose, indicating a challenging operational environment.

M K Proteins has shown fluctuating financial performance, with net sales increasing to 267.71 Cr in Mar'25 from 245.57 Cr in Mar'24, but declining from 314.86 Cr in Mar'23. Profit after tax decreased to 8.40 Cr in Mar'25, and cash flow from operating activities turned negative at -16.00 Cr, indicating challenges in cash generation.

As of 20-Oct, M K Proteins Ltd's stock price is declining at 6.63, down 3.77%, and is trading below all major moving averages, indicating a bearish trend. The stock has underperformed significantly year-to-date, with an 18.75% decline compared to the Sensex's increase, reflecting low investor confidence and sector challenges.

M K Proteins has shown fluctuating financial performance, with net sales increasing to 267.71 Cr in March 2025 from 245.57 Cr in March 2024, but declining from 314.86 Cr in March 2023. Operating profit and profits before and after tax have decreased, while total assets and liabilities rose significantly.

As of 24-Sep, M K Proteins Ltd's stock price is at 7.10, down 6.58%, and has underperformed its sector significantly. Despite a strong ability to service debt, the stock has seen a year-to-date decline of 12.99% and a one-year return of -22.49%, indicating ongoing challenges.

M K Proteins has experienced fluctuating financial performance, with net sales declining from 314.86 Cr in Mar'23 to 267.71 Cr in Mar'25, and a decrease in profit after tax to 8.40 Cr in Mar'25 from 11.21 Cr in Mar'24. Key metrics such as operating profit and earnings per share also fell, indicating significant financial challenges.

As of 11-Sep, M K Proteins Ltd is experiencing a price increase to 7.06, with a 2.32% upward change. Despite recent gains, the stock has a year-to-date decline of 13.48% and has underperformed its sector and the broader market.

M K Proteins Ltd, a microcap in the Edible Oil sector, reached its upper circuit limit today, with notable trading activity and a last traded price of Rs 7.16. The stock has shown strong market interest, with significant increases in trading volume and delivery metrics over recent sessions.

As of 10-Sep, M K Proteins Ltd's stock price has increased by 2.22% recently, but it has underperformed its sector and has a negative year-to-date performance of -15.44%. Despite short-term gains, the stock faces long-term challenges due to poor growth prospects and declining investor confidence.

M K Proteins has shown fluctuating net sales and profitability, with net sales increasing to 267.71 Cr in Mar'25 from 245.57 Cr in Mar'24, but down from 314.86 Cr in Mar'23. Operating profit and profit after tax decreased, while total assets and liabilities rose significantly in the latest fiscal year.

As of 09-Sep, M K Proteins Ltd's stock price is 6.75, up 0.9% recently, but it has a year-to-date decline of 17.28% and a significant drop of 36.97% over the past year. Despite positive quarterly results, the stock's liquidity is a concern, and it has underperformed compared to its sector and the broader market.